We've just released the following update to our investor hub: Emyria features in Washington Post Check out the full update and join in with the conversation at: investorhub.emyria.com/activity-updat… #EMD

#MDMA & #psilocybin are now controlled medicines for PTSD & treatment resistant depression. How does emyria CEO Mike Winlo envision these will be integrated into care? Full story Financial Review by Lucy Dean. ow.ly/ysM250P1XyI #PsychedelicAssistedTherapy $EMD

📢BIG NEWS! We're excited to share that $EMD has acquired Pax Centre, a leading psychological trauma care service. Our integrated clinical services will offer innovative mental health therapies and gather robust Real-World Data. Read ASX Release here 👉 ow.ly/TvK050P2cUk

📌 WATCH WEBINAR w $EMD CEO Mike Winlo CEO for a company update on the acquisition of the Pax Centre and how this enhances Emyria’s capabilities in clinical service delivery, RWD capture & innovative therapy development. Sign up to the Investor Hub to View ow.ly/QMhq50P4EfP

We've just announced first patient recruitment for our #MDMA-assisted therapy trial, EMDMA-001 Join the conversation here: investorhub.emyria.com/announcements/… #Emyria #ASX #EMD $EMD

“If the F.D.A. approves MDMA for use during therapy, this will represent an unprecedented development both for psychedelic drugs and for therapy.” A great overview of the opportunity and potential.

Completely agree. You could also substitute the term “health” for whatever the “treatment-du-jour” happens to be. Staying focussed on whatever helps people achieve their goals should be the goal for entrepreneurs and investors alike.

Editorial: Psychedelic Therapy—A New Paradigm of Care for Mental Health ja.ma/3qRbFYx

This is really neat and a great use case for why collecting broad and robust data with patients, while providing front-line care, is so important. Not just for care today but for all the future ways we will leverage technology tomorrow. It’s our mission at emyria too

This was a sobering read. “…something isn’t adding up. Even as more people flock to therapy, U.S. mental health is getting worse by multiple metrics.” time.com/6308096/therap… New ways of approaching this challenge, both diagnosis and treatment are needed.

Thrilled to welcome Greg as our new, Independent, Non-Exec Chair. Greg has an incredible passion for what we’re doing and an impressive track record founding and scaling innovative clinical services. I want to extend a heartfelt thanks to Stew for his vision, wisdom and sense

#Emyria has been featured on page 12 of The Australian Financial Review today, in an article by journalist Tom Rabe titled “The company using MDMA to treat post-traumatic stress”. Read the full article online: bit.ly/EMD-AFR-22Jan $EMD #EMD #innovation #mentalhealth #PTSD

Our CEO Mike Winlo sat down with Phoenix Global Investments to give an informal update on the great progress we've made the last 6 months. Lots of great work ahead for 2024. Thanks for following along! #mdmaresearch #ptsdtreatment

Really looking forward to my first live Spaces session with the team Phoenix Global Investments - if you're interested to learn more about what we're building over emyria / $EMD please sign-up below!

$EMD | #Emyria has received approval from the Therapeutic Goods Administration (TGA) for the first female Authorised Prescriber in Australia for MDMA-assisted therapy. Read today’s ASX release: investorhub.emyria.com/announcements/… #EMD #innovation #mentalhealth #biotech #PTSD #MDMAresearch

So proud of the team emyria. After months of hard work and preparation, our state-of-the-art Empax Centre directly boosts our capacity to support a number of unique care and research programs. We think we have a model for growth and positive impact and look forward to

Interview | #Emyria CEO Michael Winlo spoke with Jonathan Jackson at Proactive Australia about the opening of The Empax Centre, Emyria's new cutting-edge facility aimed at enhancing #mentalhealth treatments. Take a look: bit.ly/EMD-Proactive-… $EMD #EMD #innovation #research #PTSD

Stanford Medicine researchers delve into the therapeutic potential of psychedelics. Guided trips with trained professionals could pave the way for psychiatric healing by breaking rigid thought patterns. #Psychedelics #MentalHealth stanmed.stanford.edu/new-considerat…